National Navigation Metrics Quality Study to Open in March 2018

Press Releases published on March 28, 2018 in News & Updates, Standardized Metrics

Academy of Oncology Nurse & Patient Navigators, Chartis Oncology Solutions, LLC, and the American Cancer Society Collaborate to Launch First-of-Its-Kind Study

CRANBURY, NJ — The Academy of Oncology Nurse & Patient Navigators (AONN+) is launching a collaborative project with Chartis Oncology Solutions and the American Cancer Society (ACS) to execute a national multisite navigation metrics quality study. The aim of this study is to gain insight and understanding into the barriers and challenges navigation programs encounter when implementing navigation metrics. The study will also evaluate the validity and readability of the 10 selected navigation metrics to include: barriers to care; time from diagnosis to initial treatment; navigation caseload; number of navigated patients readmitted to the hospital at 30, 60, and 90 days; psychosocial distress screening; social support referrals; palliative care referrals; identifying patient learning-style preference; navigation knowledge at time of orientation; and patient experience/satisfaction with care.

Chartis Oncology Solutions will provide data capture, management, and analytics reporting of the 10 navigation metrics implemented at each study site through NAVmetrics, a cloud-based tool powered by Chartis Oncology Solutions’ ONC iQ® business intelligence platform.

The study will open in March 2018 by actively recruiting two National Cancer Institute–designated cancer centers or academic medical center providers, two Commission on Cancer–accredited community-based cancer programs, two medical oncology physician practices participating in the Oncology Care Model, and two maturing cancer programs that currently have no metrics or reports in place. Institutions interested in participating in this study can submit a formal Letter of Intent on the AONN+ website: https://aonnonline.org/pilot-study-loi.

“We look forward to collecting and reporting on this data as part of our continued efforts in building a strong, sustainable business case for navigation programs,” said Lillie Shockney, MAS, RN, BS, ONN-CG, Co-Founder and Program Director, AONN+.

“We are proud to be a part of this study and to implement our ONC iQ® unique NAVmetrics™ cloud-based tool to the cause of advancing navigation programs nationwide,” said Kelley D. Simpson, MBA, Director, Chartis Oncology Solutions.

“By harnessing this powerful information, we will create best practices to elevate navigation services and garner industry support for advancing patient-centered care delivery,” said AONN+’s Danelle Johnston, MSN, RN, ONN-CG, OCN, Chief Nursing Officer and Senior Director of Strategic Planning and Initiatives.

“The American Cancer Society is pleased to support this endeavor as part of a larger project* aimed at improving patient care through enhanced patient navigation,” said Richard C. Wender, MD, ACS Chief Cancer Control Officer. ACS will provide both programmatic and research expertise for the project.

*Merck Foundation has provided a grant to the American Cancer Society to support this work through its care coordination and patient navigation program. Information about the Merck Foundation can be found at: https://www.msdresponsibility.com/our-giving/foundation/.

About the Academy of Oncology Nurse & Patient Navigators® (www.aonnonline.org)
The Academy of Oncology Nurse & Patient Navigators, Inc. (AONN+) is the largest national specialty organization dedicated to improving patient care and quality of life by defining, enhancing, and promoting the role of oncology nurse and patient navigators. The organization, which has more than 6,000 members, was founded in 2009 to provide a network for all professionals involved and interested in patient navigation and survivorship care services in order to better manage the complexities of the cancer treatment process.

The Journal of Oncology Navigation & Survivorship® (JONS; www.jons-online.com) is the official publication of AONN+. It is published 12 times a year and features topics related to patient navigation and survivorship care. JONS offers original research, best practices, interviews, case reports, and study highlights as well as a platform through which navigators can share research and views on navigation and survivorship issues.

CONQUER: the patient voice® magazine (www.conquer-magazine.com) is AONN+’s premier forum for patients with cancer. CONQUER features articles written by and for patients with cancer, survivors, nurse navigators, and other oncology team members. This magazine addresses the issues that patients, their family members, and caregivers face every day in an easy-to-read format. Issues include interviews with patients with cancer, information on access to care, and articles on lifestyle topics such as nutrition, stress management, personal finance, and legal and employer issues. CONQUER also features patient stories that are nominated for the AONN+ Hero of Hope™ Patient Award, which is presented every year at the AONN+ Annual Conference.

Chartis Oncology Solutions (www.oncologysolutions.com)
Chartis Oncology Solutions (COS) was established in January 2018 when Oncology Solutions joined The Chartis Group, a comprehensive healthcare advisory and analytics firm. COS offers preeminent cancer care advisory and analytics services to community hospitals, health systems, National Cancer Institute–designated and academic cancer centers across the country. With unparalleled depth of expertise and experience, COS works collaboratively with healthcare professionals to strategically and operationally implement cancer care programs that enhance patient experience, improve provider performance, and impact communities. Oncology Solutions was founded in 1973 as the first firm exclusively dedicated to serving cancer providers.

American Cancer Society (www.cancer.org)
The American Cancer Society is a global grassroots force of 1.5 million volunteers saving lives in every community. As the largest voluntary health organization, the Society’s efforts have contributed to a 25% decline in the cancer death rate in the United States since 1991, driven by less smoking, better treatments, and earlier detection. We’re finding cures as the nation’s largest private, not-for-profit investor in cancer research, ensuring people facing cancer have the help they need and continuing the fight for access to quality health care, lifesaving screenings, and more. For more information, to get help, or to join the fight, call us anytime, day or night, at 800-227-2345 or visit cancer.org.

Related Items
AONN+'s ER+ Premenopausal Breast Cancer Journey Pathway Wins PM360 Pharma Choice Award
Press Releases published on February 28, 2024 in News & Updates
Cranbury, NJ (February 28, 2024)—The Academy of Oncology Nurse & Patient Navigators (AONN+) is pleased to share that PM360, a leading trade magazine for marketing decision-makers in the pharmaceutical, biotech, medical device, and diagnostic industries, has named AONN+’s estrogen-receptor-positive (ER+) Premenopausal Breast Cancer Journey Pathway, supported by TerSera Therapeutics, as the Pharma Choice Award – Variety Silver Winner.
The Academy of Oncology Nurse & Patient Navigators (AONN+) Selects Sites to Participate in National Acuity Quality Initiative
Press Releases published on October 4, 2023 in News & Updates
CRANBURY, NJ (Oct. 4, 2023) – The Academy of Oncology Nurse & Patient Navigators’ (AONN+) National Navigation Acuity Taskforce is developing a standardized, validated, evidence-based Navigation Acuity Tool for oncology navigation programs. When finalized, the acuity tool is expected to help oncology navigators characterize the intensity of the patient navigation workload, aid in the allocation of resources, and measure the effectiveness of navigation on patient outcomes.
The Academy of Oncology Nurse & Patient Navigators (AONN+) Announces New Leadership Council Members
Press Releases published on August 16, 2023 in News & Updates
CRANBURY, NJ—Each year, the AONN+ Leadership Council strives to bring novel ideas and perspectives to the table through the addition of new members.